(Billable Hours is Reuters' weekly report on lawyers and money. Please send tips or suggestions to ...

A stock split is a corporate action in which a company increases the number of its outstanding shares by dividing existing ...

Shares of ARS Pharmaceuticals bounded off their 50-day line Thursday after the biotech company reported an unexpected ...

The Danish drugmaker had said it aims to launch its blockbuster weight-loss drug, Wegovy, in India by 2026. The active ...

Nearly half of BioSpace poll respondents recently took a biopharma job they were overqualified for, a finding that didn’t ...

Australia trade war has left consumers wondering what this means for them. At least in the short term, it looks like good ...

The first time Dr. Fajgenbaum repurposed a drug, it was in an attempt to save his own life. At 25, while in medical school, ...

HYDERABAD (Reuters) -Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating ...

The drug has seen strong demand in the US and Europe, and its India launch is part of Lilly’s broader strategy to expand ...

For more on Immunovant’s new data, go here; for more on Sarepta’s gene therapy, go here; to learn more about Zealand’s deal with Roche, go here; and to read about the panels at our Breakthrough East ...

Retail pharmacies in India are facing challenges from quick commerce players, which are reshaping consumer expectations with ...

Learn how AI-driven TechBio is revolutionizing biotech in our exclusive interview with Bullfrog AI CEO Vin Singh.